Medical, Health, & Pharmacy News Headlines

Pharmacy News Archives

Medical News Today
EurekAlert!
Univ. of Maryland
Medbroadcast.com
Reuters Health/Medical
New York Times Health
BBC Health & Medical
PRWeb Pharmaceuticals

Popular Medications

Weight Loss & Diet
Pain Relief
Men's Health
Women's Health
Skin Care
Quit Smoking
Sexual Health
Muscle Relaxants
Allergy Relief
Anti-depressants
Anxiety
Sleep Aids
Gastro-intestinal

Insurance & Litigation

Viatical Settlement

Tools & Information

Currency Converter
Resource Directory
Pharmacy Affiliate

 Back to PRWeb Archives



PRWeb: 12-12-2004

Research And Markets - Falling Tag Prices: One Factor That Has Brought RFID Into The Spotlight
Research and Markets (researchandmarkets.com/reports/c10484) has announced the addition of RFID in healthcare to their offering. [PRWEB Dec 12, 2004]

Increased Number of Pharmaceutical Companies Has Been Using CROs to Accelerate the Development of New Drugs
Research and Markets(http://www.researchandmarkets.com/reports/c8629) has announced the addition of A Guide to Evaluating and Choosing CROs to their offering. [PRWEB Dec 12, 2004]

Soldiers Can Be Entrepreneurs Too - Setting Up Websites Is a Passion for One Airborne Soldier
A soldier from Ft. Polk has joined the ranks of becoming an online entrepreneur. He learned what it took by reading and attending seminars in his spare time. This week he lauched three websites selling gourmet Christmas gift baskets and tins, home security systems and even an online drugstore. [PRWEB Dec 11, 2004]

Synvisc Treatment Can Be Legally Imported from Canada
Synvisc - a common medical device used to treat osteoarthritis, can now be legally imported from Canada. Moreover, patients as well as doctors can save up to 50% on Synvisc if purchased from Canadian pharmacies. [PRWEB Dec 11, 2004]

New Drug Application Submitted to FDA for Intravenous Injection of Boniva: Would be First IV Bisphosphonate Treatment for Osteoporosis
Roche and GlaxoSmithKline (GSK) announced today the submission of a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for a novel intravenous (IV) injection formulation of its bisphosphonate Boniva (ibandronate sodium) for the treatment of postmenopausal osteoporosis. [PRWEB Dec 11, 2004]

Vioxx Lawyers and Recall Lawsuits
Hundreds of affected consumers are now bringing cases against Merck, the maker of Vioxx. [PRWEB Dec 10, 2004]

Medical Translation Services Provider RIC International Appoints Director of Medical Translation
RIC International has appointed Dr. Xaiojun (June) Xie as the company's new Director of Medical Translation. [PRWEB Dec 10, 2004]

Online Pharmacy Provides Prescription Drugs to Aid Holiday Stress
Medical consultations and prescription drugs like Xanax, Valium, and Ativan are available at Web-Doctor-Online-Pharmacy.com. [PRWEB Dec 9, 2004]

Prostate Cancer and Pancreatic Cancer: New Studies Indicate Improvement with PC Hope
Studies show that for people with pancreatic cancer and men with prostate cancer, PC Hope is associated with significant improvements in quality of life, reductions in patients’ pain rating, and a decline in PSA levels for prostate cancer patients—all without major side effects. [PRWEB Dec 9, 2004]

LogiXML and Sierra Scientific Software Partner to Create the Next Generation of Tools for Clinical Research
LogiXML, Inc., a leading provider of web-based business intelligence reporting and analysis tools, and Sierra Scientific Software, Inc. (Sierra) today announced their strategic partnership to add LogiXML’s LGX Info functionality to Sierra’s Clinical Research Information System (CRIS) version 8. [PRWEB Dec 9, 2004]

Baxa Corporation Honors Texas Children’s Hospital in Houston with 2004 Best Practices Award
Texas Children’s Hospital is the first recipient of Baxa Corporation’s award for Best Practices in the pharmacy. Texas Children’s Hospital was honored with the 2004 Best Practices Award at a Baxa customer appreciation reception held December 7, 2004, at the 30th Annual American Society of Health-System Pharmacists Mid-Year Clinical Meeting in Orlando, Florida. Pharmacy Manager, Lai Lao accepted the award on behalf of the hospital. [PRWEB Dec 9, 2004]

Peter Rost of Pfizer and Eshetu Wondemagegnehu of the World Health Organization Speak Out About Drug Re-Importation and Counterfeit Drugs at Web Conference December 10, 2004
Peter Rost of Pfizer and Eshetu Wondemagegnehu of the World Health Organization speak out about the re-importation of drugs into the USA and strategies for combating counterfeit drugs at Xtalks web conference. [PRWEB Dec 9, 2004]

Research And Markets - Study This Up To Date Guide To The Size And Shape Of The Market For OTC Healthcare On A Worldwide Level
Research and Markets (researchandmarkets.com/reports/c10683) has announced the addition of The World Market for OTC Healthcare to their offering. [PRWEB Dec 9, 2004]

Fear Over Health Sector Job Losses Could Slow the Adoption Of RFID
Wireless tagging technology could help health providers save lives, improve workflow efficiency and reduce the cost of caring for patients. However, according to a report to be published later this week by the Cambridge UK based consultancy Wireless Healthcare, a fear of job losses and the belief that the provision of healthcare cannot be automated will slow the deployment of potentially life saving technology. [PRWEB Dec 8, 2004]

Lipitor Patent To Be Reexamined At PUBPAT's Request: Patent Office Agrees There is a "Substantial Question" Regarding Blockbuster Cholesterol-Lowering Drug Patent's Validity
The United States Patent and Trademark Office has issued an Order granting the Public Patent Foundation's Request for Reexamination of Pfizer's patent on Lipitor, touted by the pharmaceutical giant as being "the best-selling treatment for lowering cholesterol and the best-selling pharmaceutical product of any kind in the world." In its Order, the Patent Office found that PUBPAT's request raised "a substantial new question of patentability" regarding all 44 claims of the patent. [PRWEB Dec 8, 2004]

Research and Markets - The Antihypertensive Market Accounted for Almost $30 Billion In the Seven Major Markets in 2003 and This Value Is Set To Rise as Prevalence Increases
Research and Markets (researchandmarkets.com/reports/c10451) has announced the addition of Commercial Insight: Antihypertensives - Can Manufacturers Maintain Value? to their offering. [PRWEB Dec 8, 2004]

Research And Markets - Is Pharmacologic Treatment Of Psychiatric Indications Is Evolving?
[PRWEB Dec 8, 2004]

Research And Markets: Have We Rediscovering The Importance Of Drug Structure For Drug Discovery?
[PRWEB Dec 8, 2004]

Problems with Flu Vaccines Raise Issues About Safety of Popular Drugs
As the FDA deals with pharmaceutical complications, alternative health medicines gain attention. [PRWEB Dec 7, 2004]

Sexy Ganja, the New All-Natural Hemp-Based Lubricating GelSlides across Canada!
Canolio, recently launched Sexy Ganja a lubricating gel created using the HomeoSativa process and combining homeopathic techniques with the use of hemp oil. Sexy Ganja offers all the therapeutic benefits of hemp along with the numerous advantages of using a lubricating gel. [PRWEB Dec 7, 2004]

Prescription Weight Loss Pills and Prescription Diet Pills Convenient to Buy Online
Prescription weight loss pills and prescription diet pills online at US-Meds.com. [PRWEB Dec 6, 2004]

Research And Markets: Has The Market For Therapeutic Antibodies Entered A New Era?
MAb therapies brought in revenues of over $5.1 billion in 2003 and will continue to grow at an impressive rate throughout the next five years. Revenues should nearly triple during this time as a result of the launch of a plethora of new MAbs and the approval of new indications for MAbs already on the market. By 2008, MAbs should account for 32 percent of all revenue in the biotech market. [PRWEB Dec 6, 2004]

Research And Markets - View These Comprehensive Profile Of 500 Healthcare And Life Sciences Companies Now
Research and Markets (researchandmarkets.com/reports/c10472) has announced the addition of Curative Health Services Inc. - Pharmatrack to their offering. [PRWEB Dec 6, 2004]

Research And Markets - All Manufacturers Of Pharmaceutical Products, Biologics, Diagnostics And Devices Controlled By The FDA And Similar Overseas Authorities Are Subject To Facility Inspections, Both Before Approval Of A New Product And Routinely Thereafter
Research and Markets (researchandmarkets.com/reports/c10621) has announced the addition of A Guide to Good Manufacturing Practice, 2nd Edition to their offering. [PRWEB Dec 6, 2004]

Research and Markets - Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery
Dublin--Research and Markets (http://www.researchandmarkets.com/reports/c10654) has announced the addition of Structure-Guided Drug Design: Rediscovering the Importance of Drug Structure for Drug Discovery to their offering [PRWEB Dec 6, 2004]

The Latest Comprehensive Review of Inkine Pharmaceutical Company Inc.
Research and Markets (researchandmarkets.com/reports/c10585) has announced the addition of Inkine Pharmaceutical Company Inc. - PharmaTrack to their offering. [PRWEB Dec 5, 2004]

Savient Pharmaceuticals Inc. - PharmaTrack
Research and Markets (researchandmarkets.com/reports/c10628) has announced the addition of Savient Pharmaceuticals Inc. - PharmaTrack to their offering. [PRWEB Dec 5, 2004]

Thermogenesis: Weight Loss, Loose Weight, Natural Fat Burner Solutions
Thermogenesis weight loss has a specific dynamic action on food that combine energetic spending and the rise metabolism which result on burning the existing fat (natural fat burner) and the fat we will absorb during the day. [PRWEB Dec 4, 2004]

Cytogen Corporation - PharmaTrack
Research and Markets (researchandmarkets.com/reports/c10475) has announced the addition of Cytogen Corporation - PharmaTrack to their offering. [PRWEB Dec 4, 2004]

Hi-Tech Pharmacal Co. Inc. - PharmaTrack
Research and Markets (researchandmarkets.com/reports/c10480) has announced the addition of Hi-Tech Pharmacal Co. Inc. - PharmaTrack to their offering [PRWEB Dec 4, 2004]

© PR Web: Medical Pharmaceuticals